title: Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.
authors.forename: Edoardo G
authors.initials: EG
authors.lastname: Giannini
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Savarino
authors.forename: Domenico
authors.initials: D
authors.lastname: Risso
authors.forename: Maria Anna
authors.initials: MA
authors.lastname: Di Nolfo
authors.forename: Paolo
authors.initials: P
authors.lastname: Del Poggio
authors.forename: Luisa
authors.initials: L
authors.lastname: Benvegnù
authors.forename: Fabio
authors.initials: F
authors.lastname: Farinati
authors.forename: Marco
authors.initials: M
authors.lastname: Zoli
authors.forename: Franco
authors.initials: F
authors.lastname: Borzio
authors.forename: Eugenio
authors.initials: E
authors.lastname: Caturelli
authors.forename: Maria
authors.initials: M
authors.lastname: Chiaramonte
authors.forename: Franco
authors.initials: F
authors.lastname: Trevisani
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D007558:Italy; D053208:Kaplan-Meier Estimate; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D018579:Patient Selection; D051437:Renal Insufficiency / Q000209:etiology*; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome